ETHealthWorld (India)
07/23/2019 21:38
Harshil donated his blood stem cells to Vansh via peripheral blood stem cell collection and gave him a second chance at life.
Search Results
Your search is now limited to «Leukemia» expert search.
Healio News
07/23/2019 14:49
FDA approves Ruxience, biosimilar to Rituxan, for lymphoma, leukemia.
Newsweek
07/23/2019 11:08
Bone marrow transplants take healthy blood-forming cells and put them into a patient's bloodstream so they can grow and make healthy red blood cells, white blood cells and platelets.
ClinicalTrials.gov
07/23/2019 08:07
Conditions : CD19 Positive; CD22 Positive; Minimal Residual Disease; Progressive Disease; Recurrent B Acute Lymphoblastic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Non-Hodgkin Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory Chronic Lymphocytic Leukemia; Refractory Non-Hodgkin Lymphoma Interventions : Biological: Autologous CD19/CD22 Chimeric Antigen Receptor T-cells; Drug: Cyclophosphamide; Drug: Fludarabine Sponsors : M.D. Anderson Cancer Center; National Cancer Institute (NCI) Not yet recruiting.
ClinicalTrials.gov
07/23/2019 08:06
Conditions : Non-Hodgkin's Lymphoma, Relapsed; Chronic Lymphoid Leukemia in Relapse; Non-Hodgkin's Lymphoma Refractory; Chronic Lymphocytic Leukemia; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic; B-cell Chronic Lymphocytic Leukemia; B-cell Non Hodgkin Lymphoma Interventions : Genetic: PBCAR20A; Drug: Fludarabine; Drug: Cyclophosphamide Sponsor : Precision BioSciences, Inc. Not yet recruiting.
ClinicalTrials.gov
07/23/2019 07:03
Following MTD/MAD identification, three separate safety run-in cohorts in neuroblastoma, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL) will be conducted to identify the recommended Phase 2 dose (RP2D) of idasanutlin in each combination, with chemotherapy or venetoclax.
Kyodo News (Japan)
07/22/2019 22:51
Butterfly rivals show support for leukemia-battling Rikako Ikee.
ScrippsNews - Health
07/22/2019 18:20
Chronic leukemia sometimes has no symptoms.
JapanNews.net
07/22/2019 16:05
Swimmers at worlds pay tribute to Japanese star with leukemia – OlympicTalk.
ClinicalTrials.gov
07/22/2019 10:23
Condition : Chronic Lymphocytic Leukemia Intervention : Sponsors : Dana-Farber Cancer Institute; National Cancer Institute (NCI) Recruiting.
PubMed News (NIH)
07/22/2019
Deregulated STAT3 signaling is frequently observed in hematological malignancies, however, the role of STAT3β in acute myeloid leukemia (AML) remains elusive.
PubMed News (NIH)
07/22/2019
These genes are involved in aging, DNA damage response and leukemia.
Clinical Epigenetics
07/21/2019 20:00
Cluster 1 contained all five samples of normal blood mononuclear cells analyzed and was therefore called “normal-like.
PR Newswire
07/21/2019 19:00
SUZHOU, China and ROCKVILLE, Md., July 21, 2019 /PRNewswire/ -- Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus and age-related diseases, today announced that the company was notified by the...
International Journal of COPD
07/21/2019 18:51
The ee-As4S4-induced erythroid differentiation was also observed in K562/AO2 cells and bone marrow mononuclear cells of CML patients.
International Journal of COPD
07/21/2019 18:47
A case of primary gastric diffuse large B-cell lymphoma occurring in chronic myeloid leukemia.
Healio News
07/21/2019 08:00
CHICAGO — Bijal D. Shah, MD, associate professor in the department of malignant hematology at Moffitt Cancer Center, spoke with HemOnc Today at ASCO Annual Meeting about the ZUMA-3 study. The phase 1/phase 2 study evaluated KTE-X19 (Kite Pharma), an investigational anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for adults with relapsed/refractory acute lymphoblastic leukemia. Shah provided an overview of end-of-phase-1 results. “We were able to identify a cell dose and a toxicity management algorithm that seems to come with highly encouraging response rates and highly.
Middle East North Africa Financial Network (MENAFN)
07/21/2019 03:13
(MENAFN - PR Newswire) SUZHOU, China and ROCKVILLE, Md., July 21, 2019 /PRNewswire/ -- Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in develop...
ClinicalTrials.gov
07/19/2019 06:50
Activating mutations in the fms like tyrosine kinase 3 (FLT3) gene are observed in approximately 30% of patients with newly diagnosed acute myeloid leukemia (AML.
PubMed News (NIH)
07/19/2019
Status Public on Jul 19, 2019 Title Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection Organism Homo sapiens Experiment type Expression profiling by high throughput sequencing Summary Chemotherapy-resistant cancer recurrence is a major cause of mortality.
On this page, you see the results of the search you have run. You may also view the following:
Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 
View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.
Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.
Show or hide the record’s caption (content description).
Show actions that can be made with the search result record.
Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.